Currently two of the drugs Zepbound for obesity and Mounjaro for Type 2 diabetes can't legally be compounded, but the FDA said it will turn a blind eye to the practice for now while it evaluates whether it was right to end the shortage earlier this fall
Farzin, L., Shamsipur, M., Samandari, L., Sadjadi, S
If you know you are heading into a stressful week or traveling to a city with higher pollution levels, you might choose to take your dose in the morning to provide that extra layer of daytime protection
At Walker Wellness & Aesthetics Clinic , we help patients address hair thinning with advanced regenerative treatments designed to improve scalp health and stimulate hair growth
Eli Lilly Moves Closer to the Next Generation of Obesity Treatment Eli Lilly has announced positive Phase 3 results for retatrutide, its investigational triple-receptor agonist targeting GLP-1, GIP, and glucagon receptors